Larimar Therapeutics (LRMR) Interest & Investment Income (2014 - 2020)
Larimar Therapeutics (LRMR) posted Interest & Investment Income of $258000.0 for Q1 2020, down 22.99% on a QoQ basis from $335000.0 in Q4 2019, and down 59.81% year-over-year from $642000.0 in Q2 2019.
Larimar Therapeutics (LRMR) Interest & Investment Income (2014 - 2020) Analysis & Trends
Larimar Therapeutics' Interest & Investment Income history runs 7 years deep, the most recent figure standing at $258000.0 for Q1 2020.
- Quarterly Interest & Investment Income fell 59.81% year-over-year to $258000.0 in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $1.6 million (down 29.11% YoY) and the FY2019 annual result came in at $2.0 million, up 5.29% from the prior year.
- Interest & Investment Income was $258000.0 for Q1 2020 at Larimar Therapeutics, down from $335000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $675000.0 in Q4 2018 and bottomed at $209000.0 in Q1 2016.
- A 5-year average of $354470.6 and a median of $266000.0 in 2017 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2016 — Interest & Investment Income soared 435.9% — and 2020, when it sank 59.81%.
- Larimar Therapeutics' Interest & Investment Income stood at $230000.0 in 2016, then rose by 11.3% to $256000.0 in 2017, then surged by 163.67% to $675000.0 in 2018, then sank by 50.37% to $335000.0 in 2019, then retreated by 22.99% to $258000.0 in 2020.
- Business Quant data shows LRMR's Interest & Investment Income at $258000.0 in Q1 2020, $335000.0 in Q4 2019, and $451000.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 258,000.00 |
| Dec 31, 2019 | 335,000.00 |
| Sep 30, 2019 | 451,000.00 |
| Jun 30, 2019 | 561,000.00 |
| Mar 31, 2019 | 642,000.00 |
| Dec 31, 2018 | 675,000.00 |
| Sep 30, 2018 | 623,000.00 |
| Jun 30, 2018 | 324,000.00 |
| Mar 31, 2018 | 267,000.00 |
| Dec 31, 2017 | 256,000.00 |
| Sep 30, 2017 | 266,000.00 |
| Jun 30, 2017 | 247,000.00 |
| Mar 31, 2017 | 227,000.00 |
| Dec 31, 2016 | 230,000.00 |
| Sep 30, 2016 | 230,000.00 |
| Jun 30, 2016 | 225,000.00 |
| Mar 31, 2016 | 209,000.00 |
| Dec 31, 2015 | 193,000.00 |
| Sep 30, 2015 | 143,000.00 |
| Jun 30, 2015 | 63,000.00 |